Business
Press Release Apr 09 2024
Strides Pharma Science Limited has informed the Exchange regarding a press release dated April 09, 2024, titled "Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated April 09, 2024, titled "Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd